vs

Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and VIAVI SOLUTIONS INC. (VIAV). Click either name above to swap in a different company.

VIAVI SOLUTIONS INC. is the larger business by last-quarter revenue ($406.8M vs $207.8M, roughly 2.0× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 1.6%, a 55.8% gap on every dollar of revenue.

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.

Viavi Solutions Inc., formerly part of JDS Uniphase Corporation (JDSU), is an American network test, measurement and assurance technology company based in Chandler, Arizona. The company manufactures testing and monitoring equipment for networks. It also develops optical technology used for a range of applications including material quality control, currency anti-counterfeiting and 3D motion sensing, including Microsoft's Kinect video game controller.

IDYA vs VIAV — Head-to-Head

Bigger by revenue
VIAV
VIAV
2.0× larger
VIAV
$406.8M
$207.8M
IDYA
Higher net margin
IDYA
IDYA
55.8% more per $
IDYA
57.4%
1.6%
VIAV

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
IDYA
IDYA
VIAV
VIAV
Revenue
$207.8M
$406.8M
Net Profit
$119.2M
$6.4M
Gross Margin
57.5%
Operating Margin
52.2%
6.1%
Net Margin
57.4%
1.6%
Revenue YoY
42.8%
Net Profit YoY
330.1%
-76.1%
EPS (diluted)
$1.33
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDYA
IDYA
VIAV
VIAV
Q1 26
$406.8M
Q4 25
$369.3M
Q3 25
$207.8M
$299.1M
Q2 25
$290.5M
Q1 25
$284.8M
Q4 24
$270.8M
Q3 24
$0
$238.2M
Q2 24
$0
$252.0M
Net Profit
IDYA
IDYA
VIAV
VIAV
Q1 26
$6.4M
Q4 25
$-48.1M
Q3 25
$119.2M
$-21.4M
Q2 25
$8.0M
Q1 25
$19.5M
Q4 24
$9.1M
Q3 24
$-51.8M
$-1.8M
Q2 24
$-52.8M
$-21.7M
Gross Margin
IDYA
IDYA
VIAV
VIAV
Q1 26
57.5%
Q4 25
57.0%
Q3 25
56.5%
Q2 25
56.3%
Q1 25
56.4%
Q4 24
59.4%
Q3 24
57.1%
Q2 24
57.8%
Operating Margin
IDYA
IDYA
VIAV
VIAV
Q1 26
6.1%
Q4 25
3.1%
Q3 25
52.2%
2.5%
Q2 25
5.3%
Q1 25
3.0%
Q4 24
8.2%
Q3 24
4.8%
Q2 24
-2.3%
Net Margin
IDYA
IDYA
VIAV
VIAV
Q1 26
1.6%
Q4 25
-13.0%
Q3 25
57.4%
-7.2%
Q2 25
2.8%
Q1 25
6.8%
Q4 24
3.4%
Q3 24
-0.8%
Q2 24
-8.6%
EPS (diluted)
IDYA
IDYA
VIAV
VIAV
Q1 26
$0.03
Q4 25
$-0.21
Q3 25
$1.33
$-0.10
Q2 25
$0.03
Q1 25
$0.09
Q4 24
$0.04
Q3 24
$-0.60
$-0.01
Q2 24
$-0.68
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDYA
IDYA
VIAV
VIAV
Cash + ST InvestmentsLiquidity on hand
$786.9M
$500.8M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$1.1B
$846.5M
Total Assets
$1.2B
$2.5B
Debt / EquityLower = less leverage
1.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDYA
IDYA
VIAV
VIAV
Q1 26
$500.8M
Q4 25
$767.4M
Q3 25
$786.9M
$545.6M
Q2 25
$425.3M
Q1 25
$396.8M
Q4 24
$509.4M
Q3 24
$920.0M
$493.1M
Q2 24
$701.7M
$491.2M
Total Debt
IDYA
IDYA
VIAV
VIAV
Q1 26
$1.1B
Q4 25
$1.2B
Q3 25
$640.5M
Q2 25
$396.3M
Q1 25
$396.1M
Q4 24
$639.3M
Q3 24
$637.6M
Q2 24
$636.0M
Stockholders' Equity
IDYA
IDYA
VIAV
VIAV
Q1 26
$846.5M
Q4 25
$834.3M
Q3 25
$1.1B
$723.9M
Q2 25
$780.2M
Q1 25
$728.8M
Q4 24
$682.8M
Q3 24
$1.2B
$702.1M
Q2 24
$931.7M
$681.6M
Total Assets
IDYA
IDYA
VIAV
VIAV
Q1 26
$2.5B
Q4 25
$2.8B
Q3 25
$1.2B
$2.1B
Q2 25
$2.0B
Q1 25
$1.9B
Q4 24
$1.7B
Q3 24
$1.2B
$1.7B
Q2 24
$973.7M
$1.7B
Debt / Equity
IDYA
IDYA
VIAV
VIAV
Q1 26
1.28×
Q4 25
1.46×
Q3 25
0.88×
Q2 25
0.51×
Q1 25
0.54×
Q4 24
0.94×
Q3 24
0.91×
Q2 24
0.93×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDYA
IDYA
VIAV
VIAV
Operating Cash FlowLast quarter
$142.2M
Free Cash FlowOCF − Capex
$142.2M
FCF MarginFCF / Revenue
68.4%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.19×
TTM Free Cash FlowTrailing 4 quarters
$13.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDYA
IDYA
VIAV
VIAV
Q1 26
Q4 25
$42.5M
Q3 25
$142.2M
$31.0M
Q2 25
$23.8M
Q1 25
$7.8M
Q4 24
$44.7M
Q3 24
$-49.2M
$13.5M
Q2 24
$-32.9M
$26.2M
Free Cash Flow
IDYA
IDYA
VIAV
VIAV
Q1 26
Q4 25
$36.9M
Q3 25
$142.2M
$22.5M
Q2 25
$18.3M
Q1 25
$1.0M
Q4 24
$36.5M
Q3 24
$-49.7M
$6.2M
Q2 24
$-33.9M
$22.4M
FCF Margin
IDYA
IDYA
VIAV
VIAV
Q1 26
Q4 25
10.0%
Q3 25
68.4%
7.5%
Q2 25
6.3%
Q1 25
0.4%
Q4 24
13.5%
Q3 24
2.6%
Q2 24
8.9%
Capex Intensity
IDYA
IDYA
VIAV
VIAV
Q1 26
Q4 25
1.5%
Q3 25
0.0%
2.8%
Q2 25
1.9%
Q1 25
2.4%
Q4 24
3.0%
Q3 24
3.1%
Q2 24
1.5%
Cash Conversion
IDYA
IDYA
VIAV
VIAV
Q1 26
Q4 25
Q3 25
1.19×
Q2 25
2.98×
Q1 25
0.40×
Q4 24
4.91×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons